Kernal Biologics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

Total Raised


Last Raised

$25M | 6 mos ago

About Kernal Biologics

Kernal Biologics is a seed-stage, synthetic biology company developing onco-selective messenger RNAs (mRNAs). The company was founded in 2016 and is based in Cambridge Massachusetts.

Kernal Biologics Headquarter Location

700 Main Street

Cambridge, Massachusetts, 02139,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kernal Biologics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kernal Biologics is included in 3 Expert Collections, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Kernal Biologics Patents

Kernal Biologics has filed 1 patent.

The 3 most popular patent topics include:

  • Gene expression
  • Molecular biology
  • Proteins
patents chart

Application Date

Grant Date


Related Topics



Molecular biology, RNA, Transcription factors, Gene expression, Proteins


Application Date


Grant Date


Related Topics

Molecular biology, RNA, Transcription factors, Gene expression, Proteins



Latest Kernal Biologics News

Amgen joins Kernal Bio’s $25M financing as the startup brings mRNA 2.0 to cancer

Jul 8, 2022

Kernal Biologics has technology that enables the delivery of messenger RNA therapies to a wider range of destinations in the body. The Series A financing comes as the startup works to advance its lead immuno-oncology program toward its first clinical test.

Kernal Biologics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Kernal Biologics Rank

  • When was Kernal Biologics founded?

    Kernal Biologics was founded in 2016.

  • Where is Kernal Biologics's headquarters?

    Kernal Biologics's headquarters is located at 700 Main Street, Cambridge.

  • What is Kernal Biologics's latest funding round?

    Kernal Biologics's latest funding round is Series A.

  • How much did Kernal Biologics raise?

    Kernal Biologics raised a total of $26.23M.

  • Who are the investors of Kernal Biologics?

    Investors of Kernal Biologics include Scale Asia Ventures, Amgen Ventures, Hummingbird Ventures, HBM Genomics, Civilization Ventures and 5 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.